Atlas FDA

Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account

Isolab, Inc. — Predicate Candidate Screening

44 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

92 daysmedian FDA review time
277 days90th percentile
44clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K951014ISOLAB'S T4 TEST KITIsolab, Inc.1996-10-185920
K950481NEONATAL CHEMISTRY SYSTEM, GALACTOSE TEST KITIsolab, Inc.1996-02-013635
K943547PHENYLALANINE TEST KITIsolab, Inc.1996-01-265540
K950803ISOLAB'S GALACTOSE-1-PHOSPHATE URIDYL TRANFERASE TEST KITS 8Isolab, Inc.1995-09-212122
K950415FLUOROSCAN NEONATALIsolab, Inc.1995-09-052170
K942222QUIK-SEP QUANTITIVE HEMOGLOBIN S CONTROLSIsolab, Inc.1995-01-202590
K942276QUIK-SEP QUANTITATIVE HEMOGLOBIN S ASSAYIsolab, Inc.1995-01-202550
K944185ISOSCANIsolab, Inc.1994-11-17830
K934013RESOLVE SYSTEMS ALKALINE PHOSPHATASE TEST KITIsolab, Inc.1994-04-262510
K923153HEMOCARD, HEMOGLOBIN C ASSAYIsolab, Inc.1994-01-275770
K931234HEMOCARD CONTROL HB-AA, AE, FAA, FAEIsolab, Inc.1993-05-11620
K930070HEMOCARD HEMOGLOBIN EIsolab, Inc.1993-04-08920
K924173HEMOCARD(TM) CONTROLIsolab, Inc.1992-12-011040
K921681CRITERION, HEMOCUE B-HEMOGLOBIN CONTROLIsolab, Inc.1992-11-172230
K911981HEMOCARD HEMOGLOBIN SIsolab, Inc.1991-10-091590
K910430HEMOCARD-ASIsolab, Inc.1991-04-15730
K910431HEMOCARD CONTROLIsolab, Inc.1991-03-11380
K905513GLYC-AFFIN(TM)-GAIsolab, Inc.1991-01-15360
K904814GLYC-AFFIN GPIsolab, Inc.1990-12-26630
K902740LDL-DIRECT CONTROLSIsolab, Inc.1990-12-071680
K901453QUIK-SEP(R) IGM RPROTEIN G AFFINITY METHODIsolab, Inc.1990-04-12160
K883411PG-NUMERIC(TM)Isolab, Inc.1989-03-152120
K880673GHB SAMPLE PAPERIsolab, Inc.1988-11-222770
K873428GLYCO-PROBE GSPIsolab, Inc.1988-04-052240
K862638VISIBLE-CHLAMYDIA(TM) TEST SYSTEMIsolab, Inc.1986-08-26470
K854712VISIBLE-HERPES TM TEST SYSTEMIsolab, Inc.1986-05-201790
K843122RESOLVE-CSFIsolab, Inc.1984-11-301141
K842152SICKLING HEMOGLOBIN CONTROLS, NORMALIsolab, Inc.1984-09-091020
K841170SICKLE HB ASSAYIsolab, Inc.1984-04-04160
K840011RESOLVE-HBIsolab, Inc.1984-02-04312
K830606QUIK-SEP IGM ISOLATION SYSTEMIsolab, Inc.1983-03-24270
K822867GLYC-AFFIN GLYCOHEMOGLOBIN ASSAYIsolab, Inc.1982-12-03670
K820630QUIK-SEP HEMOGLOBIN F ASSAY & CONTROLIsolab, Inc.1982-06-251090
K812318LIPO-SEP CHOLESTEROL AUDIT SYSTEMIsolab, Inc.1981-09-01150
K810976ALPHA-THAL SCREEN TM CONTROLIsolab, Inc.1981-05-29490
K810919HEMOGLOBIN ELECTROPHORESIS CONTROLIsolab, Inc.1981-04-23170
K801771ALPHA-THAL SCREEN 20 TEST KIT & 100 KITIsolab, Inc.1981-01-161720
K802997HDL-CHOLESTEROL CONTROL SERUMIsolab, Inc.1980-12-22270
K801410HEMOHLOBIN A2 CONTROL-LYOPHILIZEDIsolab, Inc.1980-07-21350
K800794FAST HEMOGLOBIN CONTROL-LYOPHILIZEDIsolab, Inc.1980-04-29200
K791143SICKLE-CELL F TESTIsolab, Inc.1979-07-17290
K781851HEMOGLOBIN, TESTING SYSTEMIsolab, Inc.1978-11-0740
K780998SCALPELIsolab, Inc.1978-07-27430
K771649HEMOGLOBIN A2 TESTING SYSTEMIsolab, Inc.1977-10-07390

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda